z-logo
open-access-imgOpen Access
Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans
Author(s) -
Elena Concetta Calabrese,
Sabrina Castellano,
Marisabella Santoriello,
Cristina Sgherri,
Mike Frank Quartacci,
Lucia Calucci,
Andrew G. S. Warrilow,
David C. Lamb,
Steven L. Kelly,
Ciro Milite,
Ilaria Granata,
Gianluca Sbardella,
G. STEFANCICH,
Bruno Maresca,
Amalia Porta
Publication year - 2013
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dks506
Subject(s) - azole , fluconazole , candida albicans , microbiology and biotechnology , fungicide , antifungal , corpus albicans , in vitro , fungi imperfecti , biology , chemistry , biochemistry , botany
In this study we investigated the in vitro fungistatic and fungicidal activities of CPA18 and CPA109, two azole compounds with original structural features, alone and in combination with fluconazole against fluconazole-susceptible and -resistant Candida albicans strains.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom